Its maker, Regeneron Pharmaceuticals Inc., said the company agreed to supply a single dose, given through an IV, for Trump at the request of his physician under “compassionate use” provisions, when an experimental medicine is provided on a case-by-case emergency basis, while studies of it continue.
from Hindustan Times - world https://ift.tt/2Goebyb
via IFTTT
from Hindustan Times - world https://ift.tt/2Goebyb
via IFTTT
إرسال تعليق